KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Times Interest Earned (2010 - 2013)

Jazz Pharmaceuticals' quarterly Times Interest Earned came in at $163.78 in Q3 2013, up 225.48% year-on-year from $50.32 in Q3 2012, and down 18.18% quarter-over-quarter from $200.17 in Q2 2013.

Jazz Pharmaceuticals has reported Times Interest Earned for 4 years, with the latest figure at $163.78 in Q3 2013.

  • For the quarter ending Q3 2013, Times Interest Earned rose 225.48% year-over-year to $163.78; the trailing twelve-month figure through Jun 2014 stood at $301.72 (up 291.44% YoY), and the FY2013 full-year result was $200.54, up 266.93% from the prior year.
  • Times Interest Earned for Q3 2013 stood at $163.78, down from $200.17 in the prior quarter.
  • The five-year high for Times Interest Earned was $200.17 in Q2 2013, with the low at -$251.61 in Q1 2013.
  • Average Times Interest Earned over 4 years is $40.54, with a median of $41.5 recorded in 2010.
  • Peak annual rise in Times Interest Earned reached 225.48% in 2013, while the deepest fall reached 21.85% in 2013.
  • Tracing JAZZ's Times Interest Earned over 4 years: stood at -$44.8 in 2010, then surged by 214.69% to $51.38 in 2011, then plunged by 42.05% to $29.77 in 2012, then surged by 450.07% to $163.78 in 2013.
  • The last three Times Interest Earned figures came in at $163.78 (Q3 2013), $200.17 (Q2 2013), and -$251.61 (Q1 2013), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -129.79
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3.58
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -258.33
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - 11.50
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 49.84
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.88
10 Jazz Pharmaceuticals 14.35 Bn 12.51 Bn 934.80 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2013 163.78
Jun 30, 2013 200.17
Mar 31, 2013 -251.61
Dec 31, 2012 29.77
Sep 30, 2012 50.32
Jun 30, 2012 164.28
Jun 30, 2011 51.38
Mar 31, 2011 29.09
Dec 31, 2010 -44.80
Sep 30, 2010 12.07
Jun 30, 2010 41.50